KA-Search
KA-Search performs exhaustive searches of antibody variable domain sequences to identify sequence-similar antibodies for analyses of immunogenicity and antigen specificity.
Key Features:
- Rapid and Exhaustive Search: Performs rapid, exhaustive searches across billions of antibody variable domains to identify sequences with similar amino acid composition, including within complementarity-determining regions (CDRs).
- Optimized for Antibody Specificity: Tailored for antibody sequence analysis and allows focus on any user-defined region of an antibody, including variable domains and CDRs.
- High-Throughput Performance: Enables searches across the 2.4 billion antibody sequences in the OAS database, returning the most similar sequences within 30 minutes or producing a representative subset of 10 million sequences in less than 9 seconds.
Scientific Applications:
- Immunogenicity Assessment: Identify naturally occurring, sequence-similar antibodies from healthy or diseased repertoires to inform immunogenicity analyses.
- Antigen Specificity and Therapeutic Development: Retrieve sequence-similar antibodies to support inference of antigen specificity and selection of candidates for therapeutic antibody development and disease research.
Methodology:
Searches for sequence identity across specified antibody regions, allowing user-defined regions of interest such as variable domains or specific CDRs.
Topics
Details
- License:
- BSD-3-Clause
- Cost:
- Free of charge
- Tool Type:
- library
- Operating Systems:
- Mac, Linux, Windows
- Added:
- 12/18/2023
- Last Updated:
- 11/24/2024
Operations
Publications
Olsen TH, Abanades B, Moal IH, Deane CM. KA-Search, a method for rapid and exhaustive sequence identity search of known antibodies. Scientific Reports. 2023;13(1). doi:10.1038/s41598-023-38108-7. PMID:37463925. PMCID:PMC10354155.
PMID: 37463925
PMCID: PMC10354155
Funding: - RCUK | Engineering and Physical Sciences Research Council: EP/S024093/1
- GlaxoSmithKline: EP/S024093/1